IMMUNOLOGICAL PARAMETERS 2 YEARS AFTER HIGH-TITER MEASLES IMMUNIZATION IN PERUVIAN CHILDREN

被引:48
作者
LEON, ME
WARD, B
KANASHIRO, R
HERNANDEZ, H
BERRY, S
VAISBERG, A
ESCAMILLA, J
CAMPOS, M
BELLOMO, S
AZABACHE, V
HALSEY, NA
机构
[1] LOUISIANA STATE UNIV, DEPT PEDIAT, NEW ORLEANS, LA USA
[2] MONTREAL GEN HOSP, MCGILL CTR STUDY HOST RESISTANCE, MONTREAL H3G 1A4, QUEBEC, CANADA
[3] UNIV PERUANA CAYETANO HEREDIA, INST NACL SALUD, ESCUELA MED, NAVAL MARINE DETACHMENT RES UNIT, LIMA, PERU
[4] UNIV PERUANA CAYETANO HEREDIA, DEPT MICROBIOL & MATEMAT, NAVAL MARINE DETACHMENT UNIT, LIMA, PERU
关键词
D O I
10.1093/infdis/168.5.1097
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunization with high-titer measles vaccines has been associated with excess mortality in children 2-4 years after vaccination. In this study, immunologic parameters in 64 Peruvian children who had been immunized an average of 27 months earlier with high-titer vaccines were compared with parameters in 76 recipients of low-titer vaccines. Delayed-type hypersensitivity, lymphocyte phenotype distributions by flow cytometry, and lymphoproliferation after phytohemagglutinin (PHA) stimulation were assessed. High-titer recipients had smaller indurations to tetanus, diphtheria, and Proteus (P < .05) antigens, decreased PHA stimulation (P = .04), and a lower percentage of CD4+ lymphocytes (P = .04) than low-titer recipients. After adjustment for sex, concurrent illnesses, and other variables in regression analyses, high-titer recipients had a lower percentage of CD4+ lymphocytes (P = .025) and decreased lymphocyte proliferation to PHA (P = .058). These results may provide a clue to the pathogenesis of delayed excess mortality after high-titer measles vaccination in some developing countries.
引用
收藏
页码:1097 / 1104
页数:8
相关论文
共 68 条
[1]  
AABY P, 1991, LANCET, V338, P1518, DOI 10.1016/0140-6736(91)92330-5
[2]   DELAYED EXCESS MORTALITY AFTER EXPOSURE TO MEASLES DURING THE 1ST 6 MONTHS OF LIFE [J].
AABY, P ;
BUKH, J ;
KRONBORG, D ;
LISSE, IM ;
DASILVA, MC .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 132 (02) :211-219
[3]   LONG-TERM SURVIVAL AFTER EDMONSTON-ZAGREB MEASLES VACCINATION IN GUINEA-BISSAU - INCREASED FEMALE MORTALITY-RATE [J].
AABY, P ;
KNUDSEN, K ;
WHITTLE, H ;
LISSE, IM ;
THAARUP, J ;
POULSEN, A ;
SODEMANN, M ;
JAKOBSEN, M ;
BRINK, L ;
GANSTED, U ;
PERMIN, A ;
JENSEN, TG ;
ANDERSEN, H ;
DASILVA, MC .
JOURNAL OF PEDIATRICS, 1993, 122 (06) :904-908
[4]   MEASLES VACCINATION AND REDUCTION IN CHILD-MORTALITY - A COMMUNITY STUDY FROM GUINEA-BISSAU [J].
AABY, P ;
BUKH, J ;
LISSE, IM ;
SMITS, AJ .
JOURNAL OF INFECTION, 1984, 8 (01) :13-21
[5]  
AAY P, 1988, LANCET, V2, P809
[6]  
ABO T, 1981, J IMMUNOL, V126, P1360
[7]  
[Anonymous], 1990, WKLY EPIDEMIOL REC, V65, P5
[8]  
[Anonymous], 1992, WKLY EPIDEMIOL REC, V67, P357
[9]  
ARNEBORN P, 1983, CLIN EXP IMMUNOL, V51, P165
[10]   LYMPHOCYTE-T SUB-POPULATIONS IN RELATION TO IMMUNOSUPPRESSION IN MEASLES AND VARICELLA [J].
ARNEBORN, P ;
BIBERFELD, G .
INFECTION AND IMMUNITY, 1983, 39 (01) :29-37